Your browser doesn't support javascript.
loading
LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL.
Ko, Aram; Hasanain, Mohammad; Oh, Young Taek; D'Angelo, Fulvio; Sommer, Danika; Frangaj, Brulinda; Tran, Suzanne; Bielle, Franck; Pollo, Bianca; Paterra, Rosina; Mokhtari, Karima; Soni, Rajesh Kumar; Peyre, Matthieu; Eoli, Marica; Papi, Laura; Kalamarides, Michel; Sanson, Marc; Iavarone, Antonio; Lasorella, Anna.
  • Ko A; Institute for Cancer Genetics, Columbia University Medical Center, New York, New York.
  • Hasanain M; Institute for Cancer Genetics, Columbia University Medical Center, New York, New York.
  • Oh YT; Institute for Cancer Genetics, Columbia University Medical Center, New York, New York.
  • D'Angelo F; Institute for Cancer Genetics, Columbia University Medical Center, New York, New York.
  • Sommer D; Institute for Cancer Genetics, Columbia University Medical Center, New York, New York.
  • Frangaj B; Institute for Cancer Genetics, Columbia University Medical Center, New York, New York.
  • Tran S; Sorbonne Université, INSERM U1127, CNRS UMR 7225, Brain Institute, ICM, AP-HP, University Hospital La Pitié Salpêtrière-Charles Foix, Laboratory of Neuropathology, Paris, France.
  • Bielle F; Sorbonne Université, INSERM U1127, CNRS UMR 7225, Brain Institute, ICM, AP-HP, University Hospital La Pitié Salpêtrière-Charles Foix, Laboratory of Neuropathology, Paris, France.
  • Pollo B; Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Paterra R; Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Mokhtari K; Sorbonne Université, INSERM U1127, CNRS UMR 7225, Brain Institute, ICM, AP-HP, University Hospital La Pitié Salpêtrière-Charles Foix, Neurosurgery Service, Paris, France.
  • Soni RK; Proteomics Shared Resource, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York.
  • Peyre M; Sorbonne Université, INSERM U1127, CNRS UMR 7225, Brain Institute, ICM, AP-HP, University Hospital La Pitié Salpêtrière-Charles Foix, Neurosurgery Service, Paris, France.
  • Eoli M; Sorbonne Université, INSERM U1127, CNRS UMR 7225, Brain Institute, ICM, AP-HP, University Hospital La Pitié Salpêtrière-Charles Foix, Service of Neurology 2-Mazarin, Equipe lLNCC, Paris, France.
  • Papi L; Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Kalamarides M; The Department of Experimental and Clinical, Medical Genetics Unit, Biomedical Sciences "Mario Serio," University of Florence, Florence, Italy.
  • Sanson M; Sorbonne Université, INSERM U1127, CNRS UMR 7225, Brain Institute, ICM, AP-HP, University Hospital La Pitié Salpêtrière-Charles Foix, Neurosurgery Service, Paris, France.
  • Iavarone A; Sorbonne Université, INSERM U1127, CNRS UMR 7225, Brain Institute, ICM, AP-HP, University Hospital La Pitié Salpêtrière-Charles Foix, Service of Neurology 2-Mazarin, Equipe lLNCC, Paris, France.
  • Lasorella A; Sorbonne Université, INSERM U1127, CNRS UMR 7225, Brain Institute, ICM, AP-HP, University Hospital La Pitié Salpêtrière-Charles Foix, Service of Neurology 2-Mazarin, Equipe lLNCC, Paris, France.
Cancer Discov ; 13(3): 702-723, 2023 03 01.
Article en En | MEDLINE | ID: mdl-36445254

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Neurilemoma Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Neurilemoma Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2023 Tipo del documento: Article